Manjulika Das. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adrenergic beta-1 Receptor Antagonists/adverse effectsAdrenergic beta-1 Receptor Antagonists/therapeutic useAngiotensin-Converting Enzyme Inhibitors/adverse effectsAngiotensin-Converting Enzyme Inhibitors/therapeutic useAntineoplastic Agents, Immunological/adverse effectsBisoprolol/adverse effectsBisoprolol/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/pathologyCardiotoxicityFemaleHumansPerindopril/adverse effectsPerindopril/therapeutic useRandomized Controlled Trials as TopicStroke Volume/drug effectsTime FactorsTrastuzumab/adverse effectsTreatment OutcomeVentricular Dysfunction, Left/chemically inducedVentricular Dysfunction, Left/diagnosisVentricular Dysfunction, Left/physiopathologyVentricular Dysfunction, Left/prevention & controlVentricular Function, Left/drug effectsVentricular Remodeling/drug effects
Substances： See more » Adrenergic beta-1 Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntineoplastic Agents, ImmunologicalTrastuzumabBisoprololPerindopril
Year: 2016 PMID： 27956153 DOI： 10.1016/S1470-2045(16)30639-8
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316